Company

Galmed Pharmaceuticals Ltd.

Headquarters: Tel Aviv, Israel

Employees: 18

CEO: Mr. Allen Baharaff

NASDAQ: GLMD +1.34%

Market Cap

$17,978

USD as of Jan. 1, 2024

Market Cap History

Galmed Pharmaceuticals Ltd. market capitalization over time

Evolution of Galmed Pharmaceuticals Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Galmed Pharmaceuticals Ltd.

Detailed Description

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Galmed Pharmaceuticals Ltd. has a research agreement with Gannex Pharma Co., Ltd. to develop a combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of NASH; a research and development collaboration agreement with MyBiotics Pharma Ltd. to identify the selected microbiome repertoire associated with the response to Aramchol; and a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea. The company was founded in 2000 and is headquartered in Tel Aviv, Israel.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Galmed Pharmaceuticals Ltd. has the following listings and related stock indices.


Stock: NASDAQ: GLMD wb_incandescent

Details

Headquarters:

16 Tiomkin Street

Tel Aviv, 6578317

Israel

Phone: 972 3 693 8448

Fax: 972 3 693 8447